Cavernous Sinus Thrombosis – A succinct outlook

Embed Size (px)

Citation preview

  • 8/12/2019 Cavernous Sinus Thrombosis A succinct outlook

    1/6

    67

    Official Publication of Orofacial Chronicle , India

    www.jhnps.weebly.com

    REVIEW ARTICLE

    Cavernous Sinus Thrombosis A succinct outlook

    Maliha Saman BDS1, Akheel Mohammad MDS

    2, S.P. Singh MCh

    3

    1- Consultant dental surgeon 2- Oral & Maxillofacial Surgeon, Chennai India3- Neuro and spine surgeon, Bhopal, India

    ABSTRACT:

    Cavernous sinus thrombosis is generally a fulminant process with high rates of

    morbidity and mortality. The diagnostic incidence of Cavernous Venous

    Thrombosis is increasing to 7 per 1,000, 000 as newer and more advanced imaging

    modalities emerge off late and hence every oral & maxillofacial surgeon must beaware of its occurrence and appropriate immediate management protocol. This

    article would throw light on anatomy, pathophysiology, clinical features,

    radiodiagnosis and management of Cavernous Sinus Thrombosis.

    Key Words: Cavernous sinus , thrombosis , management

    Cite thi s Ar ticle: M aliha S., Akheel M .D, S.P. Singh: Cavernous Sinus thrombosis - A

    succinct outl ook : Journal of Head & Neck physicians and surgeons Vol 2 Issue 1 2014 : Pg67-72

    INTRODUCTION:

    Cavernous sinus thrombosis is generally a fulminant process with high rates of

    morbidity and mortality. It was first described by Dease in 1778 as a rare,

  • 8/12/2019 Cavernous Sinus Thrombosis A succinct outlook

    2/6

    68

    potentially fatal complication of dental infections, orbital cellulitis, and sinusitis.

    Intracranial complications of dental abscess are very rare, but could be fatal1. Later

    the striking syndrome of swollen orbit , limited ocular mobility , impaired vision

    was first pathologically recognized by Duncan in 1821 and later clinically defined

    by Bright in 1831 as a complication of epidural and subdural infections and eyefindings by Knapp in 1868

    2,3. This article would throw light on anatomy,

    pathophysiology, clinical features, radiodiagnosis and management of Cavernous

    Sinus Thrombosis.

    PATHOPHYSIOLOGY:

    Aseptic thrombosis occurs with trauma, tumor invasion, aneurysmal expansion and

    hypercoaguable states whereas septic thrombosis is more common and occurs due

    to the intimate juxtaposition of veins, arteries, nerves, meninges, and paranasal

    sinuses accounting for the characteristic etiology and presentation. CST is more

    commonly seen with sphenoid and ethmoid and to a lesser degree with frontal

    sinusitis.Due to its complex neurovascular anatomic relationship, cavernous sinus

    thrombosis is the most important of any intracranial septic thrombosis4, 5

    .

    Staphylococcus aureus accounts for approximately 70% of all infections.

    Streptococcus pneumoniae, gram-negative bacilli, and anaerobes can also be seen.

    Fungi are a less common pathogen and may include Aspergillusand

    Rhizopusspecies6, 7, 8

    . Another reason for the pathogenesis can be due to mycotic

    embolism where following a trauma to middle third of face could lead to an

    emoboli which could get lodged into the cavernous sinus producing CST

    symptomology. Another pathophysiology behind CST could be explained due to

    phelbothrombosis occurring in cavernous sinus or any of the connecting vein

    channels8.

    The general symptoms include fever present along withthe Ocular signs following

    a thrombosis of cavernous sinus include proptosis and edema of lips and

    conjunctiva and paresis of nerve supplied by Occulomotor, Trochlear and

    Abducent nerves when involved. Chemosis, Papilledema, Periorbital sensory loss,

    Decreased corneal reflex, nuchal rigidity are other associating features presentable.

  • 8/12/2019 Cavernous Sinus Thrombosis A succinct outlook

    3/6

    69

    In conditions of oculomotor nerve involvement parasympathetic and sympathetic

    denervation leads the pupils to become small and immobile. Bilateral

    symptomology can be explained due to the involvement of intercavenous sinus as a

    result of free communication that presents on either side7, 8,9,10

    .

    DISCUSSION:

    In 1732 Winslow coined the term cavernous sinus and later Dwight Parkisnson

    referred it as the anatomic jewel box1, 9, and 10

    . The Brains venous channels include

    the dural venous sinuses and are valveless located between the inner and outer

    layers of dura extending extradurally from the superior orbital fissure backward to

    apex of petrous part of temporal bone. The cavernous sinuses lie on either side of

    pituitary fossa and are interconnected by intercavernous sinus presenting the

    primary venous reservoir for outflow of superior and inferior ophthalmic veins,

    cerebral veins and sphenoparietal sinus. It communicates to transverse sinus via

    superior petrosal sinus. The important structures that surround the cavernous sinus

    include Occulomotor, Trochlear, Ophthalmic and Maxillary nerves laterally; along

    with Internal carotid artery and the sympathetic plexus and Abducent nerve

    medially11, 12, and 13

    .

    The diagnostic incidence of Cavernous Venous Thrombosis is increasing to 7 per 1

    000 000 as newer and more advanced imaging modalities emerge off late. Females

    are more commonly affected than males, with a ratio of 1.29:13, 14

    . It presents more

    commonly among women in the 2035 year age group. There is no race

    predilection, and the associated mortality is reported to be 7%. Prospective studies

    have reported an independent survival rate of approximately 80%. Prior to the

    advent of effective antimicrobial agents, the mortality rate from CST was

    effectively 100%. With aggressive management, the mortality rate is now less than

    30%. Morbidity, however, remains high, and complete recovery is rare14

    .

    In 1926 Eagleton suggested 6 criteria which are now considered as the guidelines

    for diagnosis 1) a known site of infection 2) septicemia 3) early signs of venous

    congestion 4) ocular, maxillary, abducent nerve defecits 5) abscess or phlebitis

    contagious to cavernous sinus & 6) signs of intracranial infection though all these

  • 8/12/2019 Cavernous Sinus Thrombosis A succinct outlook

    4/6

    70

    features need not be sought but definite findings are sufficient to conclude a

    diagnosis. The most suspected differential diagnosis should include toxemia as an

    intravascular bacterial infection can present with aforesaid symptoms. Orbital vary,

    Orbital apex syndrome, Superior orbital fissure Syndrome, pseudotumour of orbit ,

    mucormycosis , orbital cellultis and acute ethmoiditis also present withoverlapping symptoms and should be kept in overview when treatment doesnt

    seem to resolve the symptoms13,15,16,17

    .

    Imaging studies remain the cornerstone of diagnosis. The diagnosis of cerebral

    venous sinus thrombosis is made on the appearance of the delta sign, a feature

    which is frequently absent on CT scans unlike scleral thickening, swollen ocular

    muscles and retrobulbar densities which are classically appreciated. The imaging

    modality of choice is magnetic resonance venography as it allows direct

    visualisation of the dural venous sinuses and the large cerebral veins. It is an

    invasive procedure with catheterisation of the jugular vein15, 16

    .

    Treatment can be broadly classified into either being aggressive or emergency

    management. The primary choice of medicine should be penicillin or a

    combination of synthetic penicillin which should be administered intravenously in

    the highest recommended dosage. Treatment options for cerebral venous sinus

    thrombosis also include anticoagulation, thrombolytic therapy, and, in some cases,

    surgical thrombectomy. Anti coagulant therapy is a bit controversial due to risk ofintracranial bleeding but doesnt outweigh the benefit of recannulization and

    dissolution of thrombus thus is emerging as a promising treatment modality15,16,17

    .

    CONCLUSION:

    In summary CST is still with us, though patients now have better survival rates. It

    is a disease primarily diagnosed with physical signs and symptoms, which requires

    prompt treatment. In our modern age of Computerization and laboratory basedmedical care CST demands the diagnostic skill of the physician whose prompt

    intervention can yield a favourable result.

  • 8/12/2019 Cavernous Sinus Thrombosis A succinct outlook

    5/6

    71

    REFERENCES:

    1. Zahller, M., et al. "Cavernous sinus thrombosis." Western Journal of Medicine133.1(1980): 44.

    2. Seltzer, Albert P. "Cavernous Sinus Thrombus with Antral Infection."Journal of theNational Medical Association54.6 (1962): 673.

    3. Rael, Jesse R., et al. "Direct thrombolysis of superior sagittal sinus thrombosis withcoexisting intracranial hemorrhage."American journal of neuroradiology18.7 (1997):1238-1242.

    4. Clifford-Jones, R. E., et al. "Cavernous sinus thrombosis."Journal of Neurology,Neurosurgery & Psychiatry45.12 (1982): 1092-1097.

    5. Stam, Jan. "Thrombosis of the cerebral veins and sinuses."New England Journal ofMedicine352.17 (2005): 1791-1798.

    6. Acheson, J., and A. Malik. "Cerebral venous sinus thrombosis presenting in thepuerperium."Emergency medicine journal: EMJ23.7 (2006): e44.

    7. Karlin, Ronald J., and William A. Robinson. "Septic cavernous sinus thrombosis."Annals of emergency medicine13.6 (1984): 449-455.

    8. Fink, J. N., and D. L. McAuley. "Cerebral venous sinus thrombosis: a diagnosticchallenge."Internal medicine journal31.7 (2001): 384-390.

    9. Sekhar, Laligam N., Manuel Dujovny, and Gutti R. Rao. "Carotid-cavernous sinusthrombosis caused by Aspergillus fumigatus: case report."Journal of neurosurgery52.1

    (1980): 120-125.10.Bentley, J. Nicole, Ramn E. Figueroa, and John R. Vender. "From presentation to

    follow-up: diagnosis and treatment of cerebral venous thrombosis."Neurosurgical focus

    27.5 (2009): E4.11.Yarington Jr, C. Thomas. "Cavernous sinus thrombosis revisited."Proceedings of the

    Royal Society of Medicine70.7 (1977): 456.

    12.Levine, Steven R., Roy E. Twyman, and Sid Gilman. "The role of anticoagulation incavernous sinus thrombosis."Neurology38.4 (1988): 517-517.

    13.Bousser, M-G. "Cerebral venous thrombosis: diagnosis and management."Journal ofneurology247.4 (2000): 252-258.

    14.Masuhr, F., and S. Mehraein. "Cerebral venous and sinus thrombosis."Journal ofneurology251.1 (2004): 11-23.

    15.Deshmukh, Vinayak, Bhavana Lakhkar, and Jayant Wagha. "CAVERNOUS SINUSTHROMBOSIS." (2008).

    16.Levine, Steven R., Roy E. Twyman, and Sid Gilman. "The role of anticoagulation incavernous sinus thrombosis."Neurology38.4 (1988): 517-517.

    17.Bhatia, K., and N. S. Jones. "Septic cavernous sinus thrombosis secondary to sinusitis:are anticoagulants indicated? A review of the literature." The Journal of Laryngology &

    Otology116.09 (2002): 667-676.

    Acknowledgement-None

  • 8/12/2019 Cavernous Sinus Thrombosis A succinct outlook

    6/6

    72

    Source of Funding-Nil

    Conflict of Interest-None Declared

    Ethical Approval-Not Required

    Correspondence Addresses :

    Maliha Saman

    Consultant Dental Surgeon

    Chennai, India

    Email Id - [email protected]

    Contact091- 08056259725

    mailto:[email protected]:[email protected]:[email protected]